Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.

David G StandaertRamon L RodriguezJohn T SlevinMichael LobatzSusan EatonKrai ChatamraMaurizio F FacherisColeen HallKavita SailYash J JalundhwalaJanet Benesh

Published in: Movement disorders clinical practice (2017)

LCIG treatment led to reductions in non-motor symptom burden and motor fluctuations in advanced PD patients. The safety profile was consistent with previous studies that used inpatient titration and outpatient titration did not appear to pose additional risk.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
palliative care
mental health
parkinson disease
risk factors
sleep quality